Dravet syndrome is a rare and severe form of epilepsy that begins in infancy and is often genetic. It is characterized by prolonged, hard-to-control seizures, often starting with a fever, followed by developmental delays and other health problems.
Tekton Research is enrolling individuals with Dravet syndrome for clinical studies.
Participating in a clinical trial may help you:
- Learn more about your condition
- Advance medical discoveries
- Access investigational therapies at no cost
- Receive compensation for time and travel expenses
Most studies provide compensation for time and travel costs. Health insurance is generally not needed to join a clinical trial.
There is never an obligation to join — we’re here to help you make the best decision.
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.